Aura Biosciences Reports First Quarter 2025 Financial Results and Business Highlights

• click to rate

  Posted by Two Blokes May 15 - Filed in Stock - 1 view
  
  First Patient Enrolled in Multi-Dose Phase 1b/2 Trial of Bel-sar in Non-Muscle-Invasive Bladder Cancer (NMIBC); Initial Data at 3 Months Expected by Year-End 2025